This study provides a basis for the new application of the old drug eltrombopag in breast cancer metastasis and highlights the value of HuR inhibitors in cancer therapy, promoting the development of novel therapies against breast cancer metastasis. The gene discussed is ELAVL1; the disease is breast carcinoma.